Relapsed follicular lymphoma
Clinical trials for Relapsed follicular lymphoma explained in plain language.
Never miss a new study
Get alerted when new Relapsed follicular lymphoma trials appear
Sign up with your email to follow new studies for Relapsed follicular lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive antibody vs stem cell transplant: which keeps lymphoma at bay?
Disease control CompletedThis phase III trial compares two consolidation treatments for people with relapsed or refractory follicular lymphoma whose cancer has shrunk after chemotherapy. Participants receive either a radioactive antibody called Zevalin or high-dose chemotherapy followed by an autologous …
Matched conditions: RELAPSED FOLLICULAR LYMPHOMA
Phase 3 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Half-Matched stem cell transplant shows promise for older blood cancer patients
Disease control CompletedThis study tested a stem cell transplant from half-matched (haploidentical) family donors for 34 people with various blood cancers. Patients received a reduced-intensity conditioning regimen of fludarabine, melphalan, and total body irradiation before the transplant. The goal was…
Matched conditions: RELAPSED FOLLICULAR LYMPHOMA
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC